Prediction of clear cell renal cell carcinoma prognosis based on an immunogenomic landscape analysis

Author:

Wang Chengwei1,Zhang Xi2,Zhu Shiqing1,Hu Bintao1,Deng Zhiyao1,Feng Huan1,Liu Bo1,Luan Yang1,Liu Zhuo1,Wang Shaogang1,Liu Jihong1,Wang Tao3,Wu Yue1

Affiliation:

1. Tongji Hospital

2. The First Clinical Medical College of Anhui Medical University

3. Shenzhen Huazhong University of Science and Technology Research Institute

Abstract

Abstract Immune-cell infiltration and tumor-related immune molecules play a key role in tumorigenesis and progression. It remains to be systematically studied how immune interactions influence clear cell renal cell carcinoma (ccRCC) molecular characteristics and prognosis. A machine learning algorithm was applied to transcriptome data from the Cancer Genome Atlas (TCGA) database in order to determine the immunophenotypic and immunological characteristics of ccRCC patients. These algorithms included single-sample gene set enrichment analyses and cell type identification. By using bioinformatics techniques, we examined the prognostic potential and regulatory networks of immune-related genes (IRGs) involved in ccRCC immune interactions. Fifteen IRGs (CCL7, CHGA, CMA1, CRABP2, IFNE, ISG15, NPR3, PDIA2, PGLYRP2, PLA2G2A, SAA1, TEK, TGFA, TNFSF14, and UCN2) were identified as prognostic IRGs associated with overall survival and were applied to construct a prognostic model. According to further analysis, the area under the receiver operating characteristic curve at one year was 0.927, but at three years was 0.822, and at five years, it was 0.717, indicating good predictive accuracy. It was also discovered that ccRCC immune interactions are governed by molecular regulatory networks. Additionally, we developed a nomogram containing the model and clinical characteristics with high prognostic potential. By systematically examining the sophisticated regulatory mechanisms, molecular characteristics, and prognostic potential of ccRCC immune interactions, we have provided an important framework for understanding ccRCC's molecular mechanisms and identifying new prognostic markers and therapeutic targets for future research.

Publisher

Research Square Platform LLC

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3